3379 results for «2026年3月22日易方达纳斯达克100溢价率»
3379 results
When angina cannot be cured with stents: what are the remaining options
22 May 2025 – From EuroPCR 2025
Explore therapeutic options for patients with angina refractory to stenting. This session reviews the efficacy and clinical outcomes of coronary sinus (CS) reducer implantation for microvascular dysfunction, factors influencing procedural success, next-generation CS reducer innovations, and the role of aspirin in angina without obstructive coronary disease.
Beyond the intervention: outcomes of CTO PCI
22 May 2025 – From EuroPCR 2025
Discover long-term outcomes and practical insights into chronic total occlusion (CTO) PCI. This session presents real-world registry data, cost-effectiveness analyses, effects of successful revascularisation in reduced ejection fraction and heart failure patients, and specific outcomes in octogenarian populations.
TAVI - Outcomes predictors
22 May 2025 – From EuroPCR 2025
Examine novel predictors of outcomes following TAVI. This session compares a new nutritional risk index against traditional scores for early post-TAVI mortality prediction and evaluates uric acid as a marker for aortic valve calcification and mortality risk in TAVI patients.
Combined LAA closure and transcatheter mitral valve repair - LIVE Case
22 May 2025 – From EuroPCR 2025
An 82-year-old male patient with a history of PM (pacemaker) implantation in 2024, and ischaemic cardiomyopathy presented with symptomatic heart failure due to severe secondary mitral regurgitation and impaired LV function (EF 40 %). He also presented with recurrent gastro-intestinal bleeding while on DOAC for atrial...
Retrograde removal of the broken sheath
22 May 2025 – From EuroPCR 2025
This session addresses complex complications during vascular access with a focus on retrograde removal of broken sheaths. Learn to recognize critical signs, manage rare but severe complications including broken guidewires in the radial artery, and explore innovative off-label solutions for challenging scenarios.
TAVI for aortic regurgitation off label
22 May 2025 – From EuroPCR 2025
Explore off-label applications of TAVI for aortic regurgitation in complex clinical scenarios. Topics include TAV-in-SAV with Trilogy valve for severe regurgitation, challenges of transcatheter prosthesis in pure aortic regurgitation, management of surgical valve perforations, and treatment strategies in post-surgical anatomies including degenerative homografts and aortic dissection.
Electrosurgical techniques in transcatheter mitral valve replacement
22 May 2025 – From EuroPCR 2025
Delve into electrosurgical techniques in transcatheter mitral valve replacement. This session covers advanced methods including the tip-to-base lampoon technique, electrosurgical laceration of failed devices, left ventricular outflow tract obstruction management, combined septal ablation and valve-in-valve procedures, and management of severe aortic regurgitation post-laceration.
Artificial intelligence in the cathlab
22 May 2025 – From EuroPCR 2025
Delve into the transformative role of artificial intelligence (AI) in the cathlab. This session covers AI applications for vulnerable plaque identification using intracoronary OCT, automated coronary angiogram analysis, rapid AI-based OCT interpretation, AI-enhanced decision-making for PCI optimization, and noninvasive microvascular resistance assessment powered by AI.
Calcified un-dilatable lesions in ACS: what should I do?
22 May 2025 – From EuroPCR 2025
Address the challenges of severely calcified undilatable lesions during acute coronary syndrome PCI. This session reviews the impact of coronary calcification on PCI strategy, highlights pitfalls in lesion preparation, and presents detailed case studies demonstrating effective treatment approaches.
Cathlab harmony: building high-performance teams
21 May 2025 – From EuroPCR 2025
Discover strategies to build and maintain high-performance teams in the cathlab environment. This session outlines how to foster a collaborative culture, address toxic behaviors, and effectively train and integrate team members to enhance teamwork and procedural success in cardiovascular interventions.
Bifurcation stenting techniques outcomes
21 May 2025 – From EuroPCR 2025
Examine the outcomes of various bifurcation stenting techniques with insights from multiple registries and trials. This session compares guidance methods and evaluates clinical results of double kissing culotte, nano-crush, POKI, and DK crush techniques in different lesion settings.
Coronary dissection : when imaging makes the difference
21 May 2025 – From EuroPCR 2025
Explore the critical role of intracoronary imaging in diagnosing and managing coronary dissections and related complications. Through case studies, learn about bailout strategies and the domino effect of decisions during PCI in acute myocardial infarction.
Challenging STEMI cases: unwanted situations
21 May 2025 – From EuroPCR 2025
Address challenging STEMI cases involving multivessel disease, high thrombus burden, and spontaneous coronary artery dissection. This session provides case-based learning on managing unexpected scenarios, diagnostic approaches, and tailored treatment strategies in complex STEMI presentations.
Challenging scenarios in the pulmonary system - Part 1
21 May 2025 – From EuroPCR 2025
This session presents challenging pulmonary system cases including high-risk and intermediate-high risk pulmonary embolism, complex congenital heart disease, and rare cardiac conditions. Understand critical management strategies for these uncommon but urgent scenarios.
How to treat - DCB
21 May 2025 – From EuroPCR 2025
Explore drug-coated balloon (DCB) therapy through detailed case studies covering calcified vessels, small diffuse vessel disease, and de novo ostial lesions. Gain practical insights on treatment approaches and key learning points to enhance your DCB practice.
Improving outcomes of NSTEMI patients
21 May 2025 – From EuroPCR 2025
Review contemporary evidence on improving outcomes for NSTEMI patients. Topics include the effects of evolocumab on stent coverage, impact of left ventricular function with kidney disease, GRACE score-based outcomes, PCI timing, and early initiation of Tafolecimab.
Right heart catheterisation and CT scan for the assessment of A-V valve treated percutaneously
21 May 2025 – From EuroPCR 2025
This session evaluates right heart catheterisation and cardiac CT imaging in the assessment of percutaneously treated atrioventricular valves. Explore clinical outcomes, invasive physiology characterization, annular remodeling, and pulmonary hypertension impact on mitral and tricuspid valve interventions.
Challenging clinical scenarios in coronary artery disease
21 May 2025 – From EuroPCR 2025
Confront challenging clinical scenarios in coronary artery disease with case-based discussions. Topics include managing multiple stent layers, late mediastinal hematoma, PCI optimization through physiology and imaging, refractory angina treatment, and acute tamponade management.
TAVI for bioprosthetic valve failure - LIVE Case
22 May 2025 – From EuroPCR 2025
A 68-year-old male patient with a history of Sapien 3 26 mm TAVI (2021), complicated by the need for two valves (one displaced in the descending aorta) and permanent pacemaker implantation, as well as endocarditis (2022), presented with symptomatic bioprosthesis failure and reduced LV function (20...
Therapeutic choices for TTVIV-TTVIR interventions
21 May 2025 – From EuroPCR 2025
Explore therapeutic choices for transcatheter tricuspid valve-in-valve and valve-in-ring interventions. Case studies cover annular ring expansion, pacing-related infection, jugular vein access valve replacement, Ebstein anomaly, and double valve-in-valve procedures in right heart disease.
